Tag Archives: Preclinical Drug Evaluation

Evaluation of 11C-Acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma

Territo PR, Maluccio M, Riley AA, McCarthy BP, Fletcher J, Tann M, Saxena R, Skill NJ. Evaluation of 11C-Acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma. BMC Med Imaging. May 2015;15(1):15. Full Text – Open Access Publication Date May 2015 How Analyze was Used “In all cases, CT…

Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1alpha,25-dihydroxycholecalciferol

Ma Y, Yu WD, Su B, Seshadri M, Luo W, Trump DL, Johnson CS. Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1alpha,25-dihydroxycholecalciferol. Cancer. July 2013;119(3):563-574. Full Text – Open Access Publication Date July 2013 How Analyze was Used “After image acquisition, raw image sets were transferred to a processing workstation…

Renoprotective effects of hepatocyte growth factor in the stenotic kidney

Stewart N, Chade AR. Renoprotective effects of hepatocyte growth factor in the stenotic kidney. Am J Physiol Renal Physiol. March 2013;304(6):F625-633. Full Text – Open Access Publication Date March 2013 How Analyze was Used “The kidney samples were scanned at 0.3-in. increments using a micro-CT scanner and reconstructed at 9-μm resolution for subsequent analysis using…